Breaking News Instant updates and real-time market news.

ACAD

Acadia

$14.03

-0.16 (-1.13%)

09:32
08/09/18
08/09
09:32
08/09/18
09:32

Acadia price target lowered to $27 from $50 at JMP Securities

JMP Securities analyst Jason Butler lowered his price target on Acadia to $27 from $50 to reflect what he called a "speed bump" for Nuplazid, but he said he still has confidence in the product's profile and commercial potential. Nuplazid growth has been hurt by the negative and, in his view, overstated safety concerns reported in the media, said Butler, who added that he believes trends discussed by management "support a timely return to growth." Butler keeps an Outperform rating on Acadia.

  • 30

    Aug

  • 31

    Aug

ACAD Acadia
$14.03

-0.16 (-1.13%)

08/09/18
HCWC
08/09/18
NO CHANGE
Target $60
HCWC
Buy
Acadia guidance creates attractive entry point, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein believes Acadia Pharmaceuticals' lowered guidance for 2018 creates an attractive entry point for the shares. The outlook clears the overhang on the company, which should allow for a more "pure" entry point for new investors seeking to capitalize on Acadia's "depressed share price," Fein tells investors in a research note. He reiterates a Buy rating on Acadia with a $60 price target.
08/07/18
STFL
08/07/18
INITIATION
Target $17
STFL
Hold
Acadia initiated with a Hold at Stifel
Stifel analyst Paul Matteis initiated coverage of Acadia with a Hold rating and a $17 price target, stating that he believes a company update on the ongoing pimavanserin FDA safety review in the second of this year or early 2019 will remove an overhang. However, his estimates are "materially below consensus" in 2019 and he expect pimavanserin to "churn its way" to $594M in PDP revenue by 2022, which is also materially below sell-side expectations.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.
08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DFFN

Diffusion Pharmaceuticals

07:38
03/20/19
03/20
07:38
03/20/19
07:38
Recommendations
Diffusion Pharmaceuticals analyst commentary  »

Diffusion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

$163.44

1.89 (1.17%)

07:38
03/20/19
03/20
07:38
03/20/19
07:38
Initiation
Advance Auto Parts initiated  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

WMT

Walmart

$99.89

0.22 (0.22%)

07:37
03/20/19
03/20
07:37
03/20/19
07:37
Initiation
Walmart initiated  »

Walmart initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

WORX

SCWorx

$7.47

-0.23 (-2.99%)

07:37
03/20/19
03/20
07:37
03/20/19
07:37
Hot Stocks
SCWorx wins signs renewal agreement with state university for $427,000 »

SCWorx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$124.16

-0.45 (-0.36%)

, SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

07:36
03/20/19
03/20
07:36
03/20/19
07:36
Recommendations
Ligand, Sage Therapeutics analyst commentary  »

Ligand receives royalty…

LGND

Ligand

$124.16

-0.45 (-0.36%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

PAVM

PAVmed

$1.05

(0.00%)

07:36
03/20/19
03/20
07:36
03/20/19
07:36
Hot Stocks
PAVmed announces NextFlo testing milestone »

PAVmed announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

TGT

Target

$78.47

0.61 (0.78%)

07:35
03/20/19
03/20
07:35
03/20/19
07:35
Initiation
Target initiated  »

Target initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGYS

Agilysys

$20.38

(0.00%)

07:35
03/20/19
03/20
07:35
03/20/19
07:35
Hot Stocks
Rosewood Hotel & Resorts selects Agilysys' InfoGenesis POS for resort »

Agilysys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

, BHC

Bausch Health

$26.29

1.745 (7.11%)

07:35
03/20/19
03/20
07:35
03/20/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

BHC

Bausch Health

$26.29

1.745 (7.11%)

DWDP

DowDuPont

$55.10

-0.12 (-0.22%)

DAL

Delta Air Lines

$50.96

0.22 (0.43%)

NKE

Nike

$87.74

-0.06 (-0.07%)

S

Sprint

$6.35

-0.11 (-1.70%)

RCII

Rent-A-Center

$19.69

-1.51 (-7.12%)

GIS

General Mills

$47.24

-0.365 (-0.77%)

YUM

Yum! Brands

$99.21

-1.04 (-1.04%)

TSG

The Stars Group

$16.95

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 04

    Apr

  • 04

    Apr

  • 16

    Apr

  • 01

    May

  • 28

    May

07:35
03/20/19
03/20
07:35
03/20/19
07:35
General news
Treasury Market Outlook: Treasury yields are a tad richer ahead of the FOMC »

Treasury Market Outlook:…

07:35
03/20/19
03/20
07:35
03/20/19
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

, GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

07:34
03/20/19
03/20
07:34
03/20/19
07:34
Hot Stocks
Google fined EUR1.49B by EU for abusive practices in online advertising »

The European Commission…

GOOG

Alphabet

$1,199.71

16.05 (1.36%)

GOOGL

Alphabet Class A

$1,203.13

15.04 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

TROX

Tronox

$12.70

0.61 (5.05%)

07:34
03/20/19
03/20
07:34
03/20/19
07:34
Recommendations
Tronox analyst commentary  »

Tronox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRTEA

Qurate Retail

$17.02

-0.27 (-1.56%)

07:33
03/20/19
03/20
07:33
03/20/19
07:33
Initiation
Qurate Retail initiated  »

Qurate Retail initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$16.57

-0.16 (-0.96%)

07:33
03/20/19
03/20
07:33
03/20/19
07:33
Downgrade
Wendy's rating change  »

Wendy's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$72.99

-0.49 (-0.67%)

, RTN

Raytheon

$180.21

-0.02 (-0.01%)

07:33
03/20/19
03/20
07:33
03/20/19
07:33
Hot Stocks
SAIC announces elimination of COO role »

Science Applications…

SAIC

SAIC

$72.99

-0.49 (-0.67%)

RTN

Raytheon

$180.21

-0.02 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 14

    May

BTU

Peabody Energy

$29.99

0.1 (0.33%)

07:33
03/20/19
03/20
07:33
03/20/19
07:33
Initiation
Peabody Energy initiated  »

Peabody Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAXN

Axon

$52.07

2.02 (4.04%)

07:32
03/20/19
03/20
07:32
03/20/19
07:32
Hot Stocks
Axon cameras, weapons and solution selected by Australian Federal Police »

Axon announced that ACT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$24.35

-0.22 (-0.90%)

07:31
03/20/19
03/20
07:31
03/20/19
07:31
Initiation
Kroger initiated  »

Kroger initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$63.66

0.21 (0.33%)

07:30
03/20/19
03/20
07:30
03/20/19
07:30
Downgrade
Restaurant Brands rating change  »

Restaurant Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$118.02

1.78 (1.53%)

07:30
03/20/19
03/20
07:30
03/20/19
07:30
Initiation
Five Below initiated  »

Five Below initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

07:30
03/20/19
03/20
07:30
03/20/19
07:30
Recommendations
FedEx analyst commentary  »

FedEx price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

UNIT

Uniti Group

$9.86

0.41 (4.34%)

, SYMC

Symantec

$23.21

0.13 (0.56%)

07:30
03/20/19
03/20
07:30
03/20/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

UNIT

Uniti Group

$9.86

0.41 (4.34%)

SYMC

Symantec

$23.21

0.13 (0.56%)

MNST

Monster Beverage

$57.87

-2.72 (-4.49%)

AXL

American Axle

$14.49

0.14 (0.98%)

NOG

Northern Oil and Gas

$2.46

-0.005 (-0.20%)

MIK

Michaels

$12.78

0.99 (8.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 16

    Apr

ZEAL

Zealand Pharma

$15.60

(0.00%)

07:30
03/20/19
03/20
07:30
03/20/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Zealand Pharma »

Zealand Pharma AS (ADS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$99.21

-1.04 (-1.04%)

07:29
03/20/19
03/20
07:29
03/20/19
07:29
Downgrade
Yum! Brands rating change  »

Yum! Brands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.